Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kai Breuer"'
Autor:
Tatiana Schmitz, Lucia Nogova, Ludwig Wildt, Kai Breuer, Beate Klimm, Thorsten Reineke, Karolin Behringer, Andreas Engert, Michael May, Volker Diehl
Publikováno v:
Journal of Clinical Oncology. 23:7555-7564
Purpose Long-term survivors of successfully treated Hodgkin’s lymphoma (HL) are at risk for late complications. Among these, infertility for female patients is of major importance. The subject of this analysis is to evaluate the menstrual status af
Autor:
Volker Diehl, Meinolf Karthaus, Thomas Wicke, U. Bethe, Gerd Fätkenheuer, Harald Seifert, Andrew J. Ullmann, Bernd Salzberger, Oliver A. Cornely, Dietmar Reichert, M. Schwonzen, Kai Breuer
Publikováno v:
International Journal of Hematology. 79:74-78
A prospective, randomized, controlled multicenter trial was performed to evaluate the efficacy and safety of once-daily oral monotherapy with 500 mg levofloxacin in comparison with 4.5 g piperacillin/tazobactam 3 times a day in patients with low-risk
Autor:
Kai Breuer, Juergen Wolf, Andreas Engert, H. Nisters-Backes, Oliver Manzke, U. Rueffer, Hans Tesch, Volker Diehl, Henning Bredenfeld, F. J. Grotenhermen, B. Lathan, Andreas Josting, M. Sieber, Peter Koch
Publikováno v:
Annals of Oncology. 12:1307-1311
UNLABELLED Infertility after treatment of patients with Hodgkin's disease (HD) is considered as a side effect of alkylating agent containing chemotherapy regimens. To investigate whether gonadal failure is related primarily to the toxic effect of che
Autor:
Ulrich Rueffer, Andreas Josting, Jeremy Franklin, Michael May, Markus Sieber, Kai Breuer, Andreas Engert, Volker Diehl for the German Hodgkin’s Lymphoma Study Group
Publikováno v:
Journal of Clinical Oncology. 19:2026-2032
PURPOSE: The cumulative incidence for non-Hodgkin lymphoma’s (NHL) after primary Hodgkin’s disease (HD) ranges between 1% and 6%. To investigate the course of disease for secondary NHL, we retrospectively analyzed patients treated within clinical
Publikováno v:
Medizinische Klinik. 95:378-384
In recent years, continuous optimization of therapy has decisively improved the prognosis of Hodgkin's disease. However, this improvement in overall survival has also led to an increase in several possible late effects which the clinician must be awa
Autor:
Dietmar Söhngen, Kai Breuer
Publikováno v:
Medizinische Therapie 2007 | 2008 ISBN: 9783540485537
Kommt es zu einer Gefasverletzung, so schutzt die Blutstillung (Hamostase) den Betroffenen vor groserem Blutverlust bzw. vor dem Verbluten. An der Blutstillung sind die Gefaswand (u. a. Endothel- und glatte Muskelzellen), die Thrombozyten und andere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1803dc3b1c7c816e0d1ba383761d6b17
https://doi.org/10.1007/978-3-540-48554-4_32
https://doi.org/10.1007/978-3-540-48554-4_32
Autor:
Hartmut Link, Michael Hallek, Eckhard Thiel, Axel Matzdorff, Agnieszka Korfel, Martin Dreyling, Hartmut Goldschmidt, Frank Hartmann, Oliver A. Cornely, Kai Breuer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdf5fc2aee0d7ccc6f6e2fe44c5dda9b
https://doi.org/10.1016/b978-343756420-8.50030-5
https://doi.org/10.1016/b978-343756420-8.50030-5
Autor:
Oliver A. Cornely, Bernd Salzberger, Kai Breuer, U. Bethe, Matthias Schrappe, H Schütt-Gerowitt, Harald Seifert, Gerd Fätkenheuer
Publikováno v:
Annals of hematology. 81(1)
A prospective, randomized, controlled monocentric trial was performed to evaluate the efficacy and safety of once daily ceftriaxone 2 g plus gentamicin 5 mg/kg in comparison to cefepime 2 g t.i.d. plus gentamicin 5 mg/kg q.d. in the treatment of neut
Autor:
Michael May, Kai Breuer, Thomas Reineke, Beate Klimm, Volker Diehl, Lucia Nogova, Karolin Behringer, Andreas Engert
Publikováno v:
Blood. 104:1314-1314
Purpose: Long term survivors of successfully treated Hodgkin’s disease (HD) are at risk for late complications. Among these, infertility for female patients is of major importance affecting many young women. The subject of this analysis is to evalu
Publikováno v:
Blood. 104:1315-1315
Background: Treatment results in Hodgkin Disease (HD) have improved tremendously over the last two decades. Therefore long term sides effects of therapy as infertility are of growing importance. However, patients (pts) with HD have increased risk for